GIS vs STRO · P/E 8.2, rev $4.56B vs rev $62.0M
General Mills Inc (GIS) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported GIS revenue for 2025-05-25 was $4.56B. Net income was $2.32B. Revenue was down 5.9% from 2025-02-23 to 2025-05-25. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
GIS currently screens at market cap $17.80B and trailing P/E 8.2. STRO currently screens at market cap $470.8M.
Not investment advice. Open the GIS and STRO stock pages for the full models.
Not investment advice.